Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase

Bioorganic & Medicinal Chemistry Letters
2015.0

Abstract

In order to explore the interactions of bisphosphonate ligands with the active site and an allosteric pocket of the human farnesyl pyrophosphate synthase (hFPPS), substituted indole and azabenzimidazole bisphosphonates were designed as chameleon ligands. NMR and crystallographic studies revealed that these compounds can occupy both sub-pockets of the active site cavity, as well as the allosteric pocket of hFPPS in the presence of the enzyme's Mg(2+) ion cofactor. These results are consistent with the previously proposed hypothesis that the allosteric pocket of hFPPS, located near the active site, plays a feed-back regulatory role for this enzyme.

Knowledge Graph

Similar Paper

Probing the molecular and structural elements of ligands binding to the active site versus an allosteric pocket of the human farnesyl pyrophosphate synthase
Bioorganic & Medicinal Chemistry Letters 2015.0
Design of potent bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase via targeted interactions with the active site ‘capping’ phenyls
Bioorganic & Medicinal Chemistry 2012.0
Novel bisphosphonate inhibitors of the human farnesyl pyrophosphate synthase
Bioorganic & Medicinal Chemistry Letters 2010.0
Thienopyrimidine Bisphosphonate (ThPBP) Inhibitors of the Human Farnesyl Pyrophosphate Synthase: Optimization and Characterization of the Mode of Inhibition
Journal of Medicinal Chemistry 2013.0
Multistage Screening Reveals Chameleon Ligands of the Human Farnesyl Pyrophosphate Synthase: Implications to Drug Discovery for Neurodegenerative Diseases
Journal of Medicinal Chemistry 2014.0
Farnesyl pyrophosphate synthase enantiospecificity with a chiral risedronate analog, [6,7-dihydro-5H-cyclopenta[c]pyridin-7-yl(hydroxy)methylene]bis(phosphonic acid) (NE-10501): Synthetic, structural, and modeling studies
Bioorganic & Medicinal Chemistry Letters 2008.0
Farnesyl Diphosphate Synthase Inhibitors With Unique Ligand-Binding Geometries
ACS Medicinal Chemistry Letters 2015.0
Protonation State and Hydration of Bisphosphonate Bound to Farnesyl Pyrophosphate Synthase
Journal of Medicinal Chemistry 2015.0
Structure–Activity Relationships Among the Nitrogen Containing Bisphosphonates in Clinical Use and Other Analogues: Time-Dependent Inhibition of Human Farnesyl Pyrophosphate Synthase
Journal of Medicinal Chemistry 2008.0
Design and Synthesis of Active Site Inhibitors of the Human Farnesyl Pyrophosphate Synthase: Apoptosis and Inhibition of ERK Phosphorylation in Multiple Myeloma Cells
Journal of Medicinal Chemistry 2012.0